financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Lifts Opinion On Mccormick & Company, Incorporated To Buy From Hold
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Lifts Opinion On Mccormick & Company, Incorporated To Buy From Hold
Mar 26, 2024 8:35 AM

11:05 AM EDT, 03/26/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We lift our 12-month target by $12 to $85, 27x our FY 25 (Nov.) EPS of $3.16 (up from $2.96; FY 24 up to $2.88 from $2.81) vs. the 30x five-year average forward P/E. FQ1 (Feb-Q) adj-EPS of $0.63 (+7% Y/Y) beat by $0.06 on revenues of $1,603M (+2% Y/Y), $51M above consensus. MKC saw a sequential improvement in volume sales (-1% Y/Y vs. -3% Y/Y in FQ4), which we expect will continue this year, especially if MKC regains some of the lost distribution it experienced over the last few years. MKC is also investing in marketing and innovation and looking to narrow price gaps to store brands. Gross margins grew 140 bps Y/Y to 37.4%, but due to SG&A de-leverage (from higher marketing), operating margins only grew 30 bps Y/Y to 14.8%. We should see stronger margins in F2H 24. MKC kept its guidance unchanged, but will likely raise it next quarter, in our opinion. We believe MKC is on track to return to double-digit EPS growth next fiscal year (FY 25), as this fiscal year (FY 24) is expected to be a heavy investment year.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Hold Opinion On Shares Of Globus Medical Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Globus Medical Inc.
May 11, 2026
09:15 AM EDT, 05/11/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our target to $84 from $98, based on 16.9x our 2027 EPS estimate, below GMED's five-year average forward P/E multiple. We raise our 2026 EPS view to $4.72...
Research Alert: CFRA Maintains Sell Opinion On Shares Of Devon Energy Corporation
Research Alert: CFRA Maintains Sell Opinion On Shares Of Devon Energy Corporation
May 11, 2026
07:20 AM EDT, 05/11/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target price of $42, raised $2, reflects relative valuation and our DCF models. On a relative basis, we apply a 4.5x multiple of enterprise value to projected 2027...
Research Alert: CFRA Lifts Opinion On Shares Of Nrg Energy, Inc. To Buy From Hold
Research Alert: CFRA Lifts Opinion On Shares Of Nrg Energy, Inc. To Buy From Hold
May 11, 2026
10:10 AM EDT, 05/11/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: Our 12-month target price is unchanged at $189, valuing shares at 19.2x our next-12-month EPS estimate of $9.86, slightly below IPP peers averaging 19.5x but significantly above NRG's highly volatile...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Albemarle Corporation
Research Alert: CFRA Maintains Hold Opinion On Shares Of Albemarle Corporation
May 11, 2026
08:00 AM EDT, 05/11/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We increase our 12-month target price by $43 to $229, valuing ALB at 27.1x on our 2027 EPS estimate, a premium to ALB's normalized average fwd P/E during the last...
Copyright 2023-2026 - www.financetom.com All Rights Reserved